Table 1 Vaccination schedules considered in the study
Vaccine schedule | First dose (Age 11–12) | Second dose (Age 16) |
|---|---|---|
No vaccine | None | None |
Q-QB-B | MenACWY | MenACWY + 2 doses of MenB (at 16 and 16.5 years of age) |
Q-Q | MenACWY | MenACWY |
Q-N | MenACWY | None |
N-Q | None | MenACWY |
Q-P-B (scenario) | MenACWY | MenABCWY at 16 years + Men B at 16.5 years |